Clinical Trials Logo

Clinical Trial Summary

With its high incidence rate and low diagnosis rate, vestibular migraine (VM) can seriously affect patients' quality of life. Current treatment of VM mainly contain rescue treatment and prophylaxis, both of which are often pharmacological-based therapies and bring a series of unavoidable side effects, which leads to poor compliance of patients. Moreover, frequent VM attacks can seriously affect patients' daily life and work. Therefore, prophylaxis treatment is of great significance for VM patients. As a non-pharmarceutical therapy, acupuncture is widely used for a wide range of migrainous and emotional disorders. Thus, it might be an alternative treatment for VM, but current evidence remains inconclusive. The aim of this randomized controlled trial is to investigate the prophylactic efficacy and safety of acupuncture therapy in patients with VM.


Clinical Trial Description

This randomized controlled trial will enroll patients with vestibular migraine from the First Affiliated Hospital of Jiaxing University. All participants will be randomly assigned to two groups. Participants will receive acupuncture in the treatment group, while participants in the control group will be treated by venlafaxine. All treatments will be given for 8 weeks. The primary outcome measures are change in vertigo/migraine days and vertigo/migraine attacks, vertigo severity, and migraine intensity per 4 weeks from baseline. The secondary outcome measures are change in dosage of rescue medication, anxiety level,depression level,and quality of life per 4 weeks from baseline. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04664088
Study type Interventional
Source First Affiliated Hospital of Jiaxing University
Contact Tianye Hu, MM
Phone 86-18357046386
Email tianye_hty@gmail.com
Status Not yet recruiting
Phase N/A
Start date January 1, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Recruiting NCT04417361 - Galcanezumab for Vestibular Migraine Phase 2
Enrolling by invitation NCT05396482 - Assesment of Hearing in Patients With Vestibular Migra
Completed NCT03979677 - Effects of Lifestyle Modification on Vestibular Migraine N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Not yet recruiting NCT05914207 - Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent N/A
Enrolling by invitation NCT06417684 - Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine Early Phase 1
Recruiting NCT04939922 - China Headache Registry Study
Recruiting NCT05472675 - Local Sensory Nerve Block in the Treatment of Vestibular Migraine N/A
Recruiting NCT05418218 - International Headache Registry Study
Suspended NCT04026516 - CAVA: Dizziness Trial N/A
Withdrawn NCT03578354 - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine Phase 2
Completed NCT02350985 - Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine Phase 4
Completed NCT03417596 - Vestibular Rehabilitation in Patients With Vestibular Migraine N/A
Enrolling by invitation NCT06267924 - SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines N/A
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A
Completed NCT02447991 - Rizatriptan for Episodic Dizziness in Vestibular Migraine Phase 2/Phase 3
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Not yet recruiting NCT05508139 - The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
Completed NCT01669304 - Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness Phase 1